Solid-State Characterization and Dissolution Properties of Lovastatin Hydroxypropyl-β-Cyclodextrin Inclusion Complex - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Solid-State Characterization and Dissolution Properties of Lovastatin Hydroxypropyl-β-Cyclodextrin Inclusion Complex
The objectives of this study were to prepare and characterize inclusion complexes of lovastatin with hydroxypropyl-β-cyclodextrin (HPβ-CD) and to study the effect of the complexes on the dissolution rate of lovastatin (LVS). The findings suggest that LVS's poor dissolution profile can be overcome by preparing its inclusion complex with HPβ-CD.


Pharmaceutical Technology



Figure 3: Fourier transform infrared spectrograms of (a) lovastatin, (B) hydroxypropyl-β-cyclodextrin, (c) the physical mixture, and complexes prepared by (d) the coevaporation method and (e) the kneading method.
The IR spectra of LVS, HPβ-CD, the physical mixture, and complexes prepared by the coevaporation and the kneading methods are presented in Figure 3. The spectrum of pure LVS presented characteristic peaks at 3510 cm–1 (alcohol O–H stretching vibration); 3016 cm–1 (olefinic C–H stretching vibration); 2970, 2930, and 2876 cm–1 (methyl and methylene C–H stretching vibration); 1725, 1713, and 1690 cm–1 (lactone and ester carbonyl stretch [hydrogen bonded for 1711 and 1700 cm–1 ]); 1430, 1378, and 1350 cm–1 (methyl and methylene bending vibration); 1275, 1228, 1080, and 1050 cm–1 (lactone and ester C–O–C bending vibration); 972 cm–1 (alcohol C–OH stretch); and 873 cm–1 (trisubstituted olefinic C–H wag).

The IR spectrum of the HPβ-CD is characterized by intense bands at 3300–3500 cm–1 because of O–H stretching vibrations. The vibration of the –CH and CH2 groups appears in the 280–3000-cm–1 region. The spectrum patterns of the physical mixture correspond with the superposition of the IR spectra of the two components. The absence of characteristic peaks of LVS and the presence of characteristic peaks caused by HPβ-CD in the IR spectra of complexes prepared by the coevaporation and the kneading methods indicate that LVS is inside the cavity of HPβ-CD. The IR spectra of the physical mixture and complexes prepared by the coevaporation method and the kneading methods showed most of the characteristic peaks were similar to that of HPβ-CD, except one peak at 1700 cm–1 for lactone and ester carbonyl stretching vibration (hydrogen bonded for 1711 and 1700 cm–1 ), which is characteristic of LVS. This effect indicates that the pyrol part of LVS remains outside the HPβ-CD, whereas the remaining part fits inside the HPβ-CD cavity.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here